Groundbreaking Medical Announcement on Transcatheter Aortic-Valve Replacement Made at St. Clair Hospital Heart Team Summit

MT. LEBANON, Pa.  (August 16, 2019) – Lead author of a groundbreaking study on Transcatheter Aortic Valve-Replacement (TAVR), Michael Mack, M.D., Medical Director of Cardiovascular Surgery at Baylor Health Care System, announced today FDA approval of TAVR for low risk patients at St. Clair Hospital’s Heart Team Summit.

This announcement expands the availability of TAVR for all patients with aortic stenosis, not just those who are at high-risk.

TAVR is offered at St. Clair Hospital by Andy Kiser, M.D., and Ryan Zuzek, M.D.

About St. Clair Hospital

St. Clair Hospital is a nationally recognized integrated health system with more than 2,500 employees and 600 physicians serving 500,000 residents of southwestern Pennsylvania. In 2016, it became a member of the Mayo Clinic Care Network. As the region’s largest independent hospital, St. Clair participates with all major insurers.